Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
GLP-1 Success Story GLP-1 agonists (also called GLP-1RAs), and related drugs like dual agonists of gastric inhibitory polypeptide (GIP)/GLP-1, have revolutionized obesity treatment by demonstrating significant and sustained weight loss in clinical trials and real-world use
The news: The FDA this week issued 30 warning letters to telehealth companies selling compounded GLP-1 weight loss drugs over false or misleading marketing claims
As for appetite changes, many patients report less food noise or cravings
Discussion Our findings demonstrate that GLP-1 receptor agonist-based therapeutics significantly disrupt the interoceptive stimulus effects of alcohol, highlighting a potential therapeutic mechanism through which these medications may reduce alcohol consumption and motivation
Tirzepatide & Weight Loss In early studies, tirzepatide significantly lowers a patients body weight
